MYBF yields 4.79% · PFE yields 6.13%● Live data
📍 MYBF pulled ahead of the other in Year 1
Combined, MYBF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MYBF + PFE for your $10,000?
Muncy Bank Financial, Inc., together with its subsidiaries, provides banking products and services to individuals and businesses in Pennsylvania. It accepts savings, money market, and checking accounts, as well as demand, time, and certificates of deposit. The company's loan products include mortgage, home equity, vehicle, commercial mortgages, personal, commercial equipment loans, as well as business and real estate loans. It also offers investment services, such as wealth transition, retirement accounts, college savings strategies, insurance protection, portfolio analysis, brokerage services, tax-deferred investments, and tax-advantaged income; and wealth management and trust services comprising estate administration, investment management services, guardianship, and IRA/retirement accounts, as well as living/grantor, charitable, irrevocable, and special needs trusts. In addition, the company provides cash management services consisting of ACH origination, check positive pay, online wire transfer, and remote deposit capture services; merchant services; and telephone and electronic banking services, as well as debit and credit cards. It operates through eight offices located in Muncy, Hughesville, Clarkstown, Montoursville, Dewart, Avis, Linden, and Montgomery, Pennsylvania. The company was founded in 1893 and is based in Muncy, Pennsylvania.
Full MYBF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.